KFKevin D. Frick

Kevin D. Frick

*This is an algorithmically generated author record based on publicly available information.

Kevin D. Frick has a total of 146 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Early childhood health promotion and its life course health consequences

    by Sai Ma, Kevin D. Frick, Alyssa Crawford, Bernard Guyer

    Health and Education in Early Childhood - February 2015

  • Who Participates in Chronic Disease Self-management (CDSM) Programs? Differences Between Participants and Nonparticipants in a Population of Multimorbid Older Adults

    by Melissa Dattalo, Erin R. Giovannetti, Daniel ScD Scharfstein, Chad Md Boult, Stephen Wegener, Jennifer L. Wolff, Bruce Leff, Kevin D. PhD Frick, Lisa Mhs Reider, Katherine Rn Frey, et al.

    Background: Self-care management is recognized as a key component of care for multimorbid older adults; however, the characteristics of those most likely to participate in Chronic Disease Self-Management (CDSM) programs and strategies to maximize participation in such programs are unknown. Objectives: To identify individual factors associated with attending CDSM programs in a sample of multimorbid older adults. Research Design: Participants in the intervention arm of a matched-pair cluster-randomized controlled trial of the Guided Care model were invited to attend a 6-session CDSM course. Logistic regression was used to identify factors independently associated with attendance. Subjects: All subjects (N=241) were aged 65 years or older, were at high risk for health care utilization, and were not homebound. Measures: Baseline information on demographics, health status, health activities, and quality of care was available for CDSM participants and nonparticipants. Participation was defined as attendance at 5 or more CDSM sessions. Results: A total of 22.8% of multimorbid older adults who were invited to CDSM courses participated in 5 or more sessions. Having better physical health (odds ratio [95% confidence interval]=2.3 [1.1–4.8]) and rating one’s physician poorly on support for patient activation (odds ratio [95% confidence interval]=2.8 [1.3–6.0]) were independently associated with attendance. Conclusions: Multimorbid older adults who are in better physical health and who are dissatisfied with their physicians’ support for patient activation are more likely to participate in CDSM courses.


  • The Costs of Experience Corps® in Public Schools

    by Kevin D. Frick, Sylvia McGill, Erwin J. Tan, George W. Rebok, Michelle C. Carson, Elizabeth K. Tanner, Linda P. Fried

    Objective: To describe the annual operational costs of a mature Experience Corps® program in elementary schools in the Baltimore City Public School System. Methods: Systematic records of expenditures kept by the community partner, Greater Homewood Community Corporation, to be reported to funders were made available for analysis. Expenditures were aggregated to the level of fiscal year and grouped in categories in consultation with the community partner. Results: Expenditures to provide reimbursement to volunteers and to administer this complex volunteer program in an environment in which the school district needed additional management resources for such a program dominate the total expenditures. In the 2008 fiscal year, the program provided 158,305 hours of older adult volunteer service to public elementary schools in Baltimore City and the cost per volunteer hour was $9.79; in the 2009 fiscal year the program provided 157,238 hours of older adult volunteer service and the cost per volunteer hour was $9.60. This suggests consistency and may also suggest that the program is becoming more efficient over time. Conclusion: The costs presented represent the costs of running a mature program after an initial investment has been made. These costs would need to be compared with the short-term and long-term benefits to the older adult volunteers, the school children, other school personnel, and the schools' and volunteers' communities to perform a comprehensive benefit-cost analysis to inform public policy.


  • Open Access

    Health Services Utilization and Cost of Retinitis Pigmentosa

    by Kevin D. Frick, M. Christopher Roebuck, Joshua I. Feldstein, Catherine A. McCarty, Lori L. Grover

    Retinal dystrophies are characterized by degeneration of photoreceptor and retinal pigment epithelium cells and are the major cause of incurable hereditary blindness in the Western world.1 Retinitis pigmentosa (RP) is the most frequent cause of inherited visual impairment (VI), with a prevalence of 1:4000, and is estimated to affect 50 000 to 100 000 people in the United States and approximately 1.5 million people worldwide.2,3 Manifesting initially with a deficiency in night vision, the course of RP is characterized by deterioration of specialized light-absorbing cells in the retina, leading to progressive loss of peripheral and day vision and, over decades, in most cases, severe VI or blindness. Age at onset can vary from early childhood to adulthood, with photoreceptor degeneration often present several years before a patient reports visual symptoms.4 Approximately 45 causal genes have been identified in RP, and these account for two-thirds of cases. In general, RP is a progressive disease, with exponential decline in the visual field area of approximately 9% per year and in cone electroretinographic amplitude of 10% per year.3,5-9


  • Open Access

    Associations among Visual Acuity and Vision- and Health-Related Quality of Life among Patients in the Multicenter Uveitis Steroid Treatment Trial

    by Kevin D. Frick, Lea T. Drye, John H. Kempen, James P. Dunn, Gary N. Holland, Paul Latkany, Narsing A. Rao, H. Nida Sen, Elizabeth A. Sugar, Jennifer E. Thorne, et al.

    Purpose.: To evaluate the associations between visual acuity and self-reported visual function; visual acuity and health-related quality of life (QoL) metrics; a summary measure of self-reported visual function and health-related QoL; and individual domains of self-reported visual function and health-related QoL in patients with uveitis. Methods.: Best-corrected visual acuity, vision-related functioning as assessed by the NEI VFQ-25, and health-related QoL as assessed by the SF-36 and EuroQoL EQ-5D questionnaires were obtained at enrollment in a clinical trial of uveitis treatments. Multivariate regression and Spearman correlations were used to evaluate associations between visual acuity, vision-related function, and health-related QoL. Results.: Among the 255 patients, median visual acuity in the better-seeing eyes was 20/25, the vision-related function score indicated impairment (median, 60), and health-related QoL scores were within the normal population range. Better visual acuity was predictive of higher visual function scores (P ≤ 0.001), a higher SF-36 physical component score, and a higher EQ-5D health utility score (P < 0.001). The vision-specific function score was predictive of all general health-related QoL (P < 0.001). The correlations between visual function score and general quality of life measures were moderate (ρ = 0.29–0.52). Conclusions.: The vision-related function score correlated positively with visual acuity and moderately positively with general QoL measures. Cost–utility analyses relying on changes in generic healthy utility measures will be more likely to detect changes when there are clinically meaningful changes in vision-related function, rather than when there are only changes in visual acuity. (ClinicalTrials.gov number, NCT00132691.)


  • Open Access

    Racial Disparities in Medical Expenditures within Body Weight Categories

    by Sai Ma, Kevin D. Frick, Sara Bleich, Lisa Dubay

    Despite federal guidelines calling for the reduction of obesity and elimination of health disparities, black–white differences in obesity prevalence and in medical expenditures and utilization of health care services persist. To examine black–white differences in medical expenditures and utilization of health care services (office-based visits, hospital outpatient visits, ER visits, inpatient stays and prescription medication) within body weight categories. This study used data from the 2006 Medical Expenditures Panel Survey (MEPS) and included 15,164 non-Hispanic white and non-Hispanic black adults. We used a standard two-part econometric model to examine black–white differences in how expenditures (total annual medical expenditures and expenditures for each type of service) vary within body weight categories. Blacks in each weight category were less likely to use any medical care than their white counterparts, even after controlling for socio-demographic characteristics, perceived health status, health conditions and health beliefs. Among those who received medical care, there is no significant difference in the total amount spent on care between blacks and whites. Compared to whites, blacks in each body weight category were significantly less likely to use office-based visits, hospital outpatient visits, and medications. Among those who used medications, blacks had significantly lower expenditures than whites. Blacks in obese class II/III were significantly less likely to have any medical expenditures on inpatient care than their white counterparts. Black–white racial differences in total medical expenditures were observed in each body weight category and were significantly different in the obese I class, overweight, and healthy weight categories. Obese blacks also spent a smaller amount than obese whites—the insignificance might be due to the smaller sample size. These differences cannot be fully explained by socio-demographics, health conditions, or health beliefs. Black–white differences in medical expenditures may be largely due to relatively inexpensive types of care (office-based visits, outpatient care, medication) rather than more costly ones (inpatient care, ER).


  • Open Access

    What the comprehensive economics of blindness and visual impairment can help us understand

    by Kevin D Frick

    Since the year 2000, the amount written about the economics of blindness and visual impairment has increased substantially. In some cases, the studies listed under this heading are calculations of the costs related to vision impairment and blindness at a national or global level; in other cases the studies examine the cost-effectiveness of strategies to prevent or modify visual impairment or blindness that are intended to be applied as a guide to treatment recommendations and coverage decisions. In each case the references are just examples of many that could be cited. These important studies have helped advocates, policy makers, practitioners, educators, and others interested in eye and vision health to understand the magnitude of the impact that visual impairment and blindness have on the world, regions, nations, and individuals and the tradeoffs that need to be made to limit the impact. However, these studies only begin to tap into the insights that economic logic might offer to those interested in this field. This paper presents multiple case studies that demonstrate that the economics of blindness and visual impairment encompasses much more than simply measures of the burden of the condition. Case studies demonstrating the usefulness of economic insight include analysis of the prevention of conditions that lead to impairment, decisions about refractive error and presbyopia, decisions about disease and injury treatment, decisions about behavior among those with uncorrectable impairment, and decisions about how to regulate the market all have important economic inputs.


  • Open Access

    Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trial

    by Sarah S Casagrande, Gerald J Jerome, Arlene T Dalcin, Faith B Dickerson, Cheryl A Anderson, Lawrence J Appel, Jeanne Charleston, Rosa M Crum, Deborah R Young, Eliseo Guallar, et al.

    Background: Overweight and obesity are highly prevalent among persons with serious mental illness. These conditions likely contribute to premature cardiovascular disease and a 20 to 30 percent shortened life expectancy in this vulnerable population. Persons with serious mental illness need effective, appropriately tailored behavioral interventions to achieve and maintain weight loss. Psychiatric rehabilitation day programs provide logical intervention settings because mental health consumers often attend regularly and exercise can take place on-site. This paper describes the Randomized Trial of Achieving Healthy Lifestyles in Psychiatric Rehabilitation (ACHIEVE). The goal of the study is to determine the effectiveness of a behavioral weight loss intervention among persons with serious mental illness that attend psychiatric rehabilitation programs. Participants randomized to the intervention arm of the study are hypothesized to have greater weight loss than the control group.Methods/Design: A targeted 320 men and women with serious mental illness and overweight or obesity (body mass index ≥ 25.0 kg/m2) will be recruited from 10 psychiatric rehabilitation programs across Maryland. The core design is a randomized, two-arm, parallel, multi-site clinical trial to compare the effectiveness of an 18-month behavioral weight loss intervention to usual care. Active intervention participants receive weight management sessions and physical activity classes on-site led by study interventionists. The intervention incorporates cognitive adaptations for persons with serious mental illness attending psychiatric rehabilitation programs. The initial intensive intervention period is six months, followed by a twelve-month maintenance period in which trained rehabilitation program staff assume responsibility for delivering parts of the intervention. Primary outcomes are weight loss at six and 18 months.Discussion: Evidence-based approaches to the high burden of obesity and cardiovascular disease risk in person with serious mental illness are urgently needed. The ACHIEVE Trial is tailored to persons with serious mental illness in community settings. This multi-site randomized clinical trial will provide a rigorous evaluation of a practical behavioral intervention designed to accomplish and sustain weight loss in persons with serious mental illness.Trial Registration: Clinical Trials.gov NCT00902694